Tevogen Inc.
corporate_fare Company Profile
Tevogen Inc. (NASDAQ:TVGN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 32 items for TVGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-17, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for TVGN spans S-3, 10-Q, SCHEDULE 13D/A, 8-K.
Recent high-impact activity:
- Tevogen Registers 1.03M Lender Shares for Resale as Cash Falls to $144,713
- Tevogen Q3: $144,713 Cash, Missed Payroll, $28.6M Related-Party Lifeline
- CEO Ryan Saadi Granted 50 Million Restricted Shares Tied to $1 Billion Revenue Target
- Tevogen Signs LOI to Explore HRK Healthcare Acquisition, Eyes $100M Revenue
- Tevogen Ties CEO's 8M Share Grant to $1B Revenue Milestone
Financial Snapshot
Short Interest & Short Volume
4.33 days to coverFINRA reported short interest of 54,853 shares in TVGN as of the October 30, 2026 settlement, a 1.0% decrease from the prior period — about 4.3 days to cover at its recent average daily volume. On November 20, 2026, 12.5% of TVGN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for TVGN, detected from its recent SEC filings · based on capital-structure filings through 2026-06-26.
Major Investor Registers Shares for Resale · Significant Potential Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →